Induction of b-cell mass regeneration is a potentially curative treatment for diabetes. We have recently found that long-term gastrin treatment results in improved metabolic control and b-cell mass expansion in 95% pancreatectomised (Px) rats. In this study, we investigated the underlying mechanisms of gastrin-induced b-cell mass expansion after Px. After 90%-Px, rats were treated with gastrin (PxCG) or vehicle (PxCV), pancreatic remnants were harvested on days 1, 3, 5, 7, and 14 and used for gene expression, protein immunolocalisation and morphometric analyses. Gastrin-and vehicle-treated Px rats showed similar blood glucose levels throughout the study. Initially, after Px, focal areas of regeneration, showing mesenchymal cells surrounding ductal structures that expressed the cholecystokinin B receptor, were identified. These focal areas of regeneration were similar in size and cell composition in the PxCG and PxCV groups. However, in the PxCG group, the ductal structures showed lower levels of keratin 20 and b-catenin (indicative of duct dedifferentiation) and higher levels of expression of neurogenin 3 and NKX6-1 (indicative of endocrine progenitor phenotype), as compared with PxCV rats. In PxCG rats, b-cell mass and the number of scattered b-cells were significantly increased compared with PxCV rats, whereas b-cell replication and apoptosis were similar in the two groups. These results indicate that gastrin treatment-enhanced dedifferentiation and reprogramming of regenerative ductal cells in Px rats, increased b-cell neogenesis and fostered b-cell mass expansion.
Introduction b-cell mass reduction is a central event in the development of types 1 and 2 diabetes, and b-cell regeneration is a potentially curative treatment for the disease. Strategies aiming to regenerate b-cell mass include stimulation of replication and survival of b-cells, generation of new b-cells from progenitor cells and reprograming of other cell types that could induce or stimulate b-cell regeneration in diabetic patients is the subject of intensive research.
The major endocrine b-cell expansion takes place during the development of embryonic pancreas. Development of the pancreas occurs by the sequential differentiation of multipotent pancreatic progenitors that give rise to both, exocrine and endocrine lineages (Fishman & Melton 2002 , Gu et al. 2002 . A subpopulation of endocrine progenitor cells expressing the pro-endocrine factor neurogenin 3 (NEUROG3) appears within the multipotent pancreatic progenitor pool (Gu et al. 2002) and subsequent hierarchical expression of specific transcription factors results in progressive differentiation and maturation into different hormone-producing islet cells (Collombat et al. 2006 , Murtaugh 2007 , Rieck et al. 2012 . NEUROG3 expression peaks during the major endocrine cell differentiation phase of the embryonic pancreas, known as 'secondary transition'. During this period gastrin and its high-affinity receptor cholecystokinin B receptor (CCKBR) are expressed within the endocrine domain of the developing pancreas (Larsson et al. 1976 , Suissa et al. 2013 . In post-natal life, pancreatic gastrin and CCKBR expression declines along with b-cell neogenesis (Rooman et al. 2001 , Suissa et al. 2013 . Ectopic expression of gastrin and transforming growth factor alpha in the pancreas or administration of gastrin in combination with epidermal growth factor or glucagon-like peptide 1 analogues has been shown to increase the b-cell mass and/or to improve glucose tolerance (Wang et al. 1993 , Rooman et al. 2002 , Suarez-Pinzon et al. 2005 , 2008a , supporting a potential role of gastrin in the treatment of diabetes. In a recent study, we have found that long-term gastrin treatment improved glucose tolerance by increasing the functional b-cell mass in 95% pancreatectomised (Px) rats (Téllez et al. 2011) .
Subtotal Px results in pancreatic regeneration with increased exocrine and endocrine cell mass expansion (Bonner-Weir et al. 1983 , 1993 , Téllez et al. 2011 and has been extensively used as a model for the study of pancreatic endocrine regeneration in the adult (Bonner-Weir et al. 1993 , Xu et al. 1999 , Fernández et al. 2006 , Figeac et al. 2012 . Increased b-cell replication and neogenesis have been demonstrated to play a role in b-cell regeneration after partial Px, but genetic cell lineage tracing studies have shown discrepant results with respect to the importance of neogenesis during normal growth and after pancreatic injury (Inada et al. 2008 , Xu et al. 2008 , Solar et al. 2009 , Kopinke et al. 2011 , Kopp et al. 2011 , Xiao et al. 2013 . After partial Px, regenerative ducts branch from the common pancreatic duct (CPD) and acquire a progenitorlike phenotype, based on the expression of a cadre of transcription factors expressed in the developing pancreas (i.e. Pdx1, Neurog3, Sox9, Hnf1b, Ptf1a and Nkx6.1), and form focal areas of regeneration (Li et al. 2010) . New b-cells are formed within these areas, even though their contribution to the b-cell mass expansion after Px is unclear.
In this study, we investigated the mechanisms underlying gastrin-induced b-cell expansion in 90% Px rats. Gastrin treatment enhanced the dedifferentiation and reprogramming of regenerative ductal cells, and increased b-cell neogenesis and b-cell mass regeneration.
Material and methods

Animals
Experimental procedures were reviewed and approved by the Ethical Committee of the University of Barcelona. Male Sprague-Dawley rats (Harlan Interfauna Ibérica, Sant Feliu de Codines, Spain), 4-to 5-weeks-old and weighing approximately 100 g were subjected to a 90% Px. Three groups were studied: 90%-Px rats treated with gastrin (PxCG), 90%-Px rats treated with vehicle (PxCV) and sham-Px rats treated with vehicle (SCV). Treatment with (15 leu) gastrin-17 (150 mg/kg, Transition Therapeutics, Toronto, Ontario, Canada) (Téllez et al. 2011) or vehicle (PBS) was started immediately before surgery. All animals received s.c. injections every 12 h from the day of surgery until harvesting of pancreatic remnants. Fed morning plasma glucose levels were monitored daily from the snipped tail with a portable meter. The blood samples were taken approximately 12 h after the previous gastrin injection and just before the next injection.
Px and pancreas remnant harvesting
Pancreatectomy 90%-Px was performed as described previously (Bonner-Weir et al. 1983) . Briefly, animals were anesthetised with 5% isofluorane (Forane, Abbott) and anesthesia was maintained with an isofluorane (1.5%)-air mixture. Ninety percent of the pancreas was removed by gentle abrasion with cotton applicators, being careful to leave major blood vessels intact; the pancreatic remnant was the tissue between the common bile duct and the first loop of the duodenum, and corresponded to 8.5G0.8% of the total pancreas. Sham Px was accomplished by breaking splenic and duodenal mesenteric connections and by gently handling the pancreas with the fingertips. Immediately after surgery, the animals received one dose (2.5 mg/kg) of meloxicam (Metacam, Boehringer Ingelheim, Germany) that was subsequently administered for the next 3 days after surgery for analgesia.
Tissue harvesting For sham-operated animals, the equivalent of the remaining 10% tissue left after 90%-Px (remnant-equivalent) was collected on day 1 (nZ3), day 3 (nZ3), day 5 (nZ3), day 7 (nZ3), and day 14 (nZ5) after sham surgery. Tissue weight was similar among remnants from 1 to 7 days after surgery, thus pancreatic remnants were pooled into one single group (SCV, nZ12). For Px rats, pancreatic remnants were harvested on day 1 (nZ10), day 3 (nZ10), day 5 (nZ10), day 7 (nZ10), and day 14 (nZ10) after surgery. The excised pancreatic remnants were weighed and fixed in 4% PBS-buffered paraformaldehyde and processed for paraffin embedding. For the gene expression analysis, remnant-equivalents were harvested on days 1, 3, 5, and 7 after sham surgery and were pooled in one single group (SCV, nZ6), and pancreatic remnants were harvested on day 1 (nZ10), day 3 (nZ10), day 5 (nZ8), and day 7 (nZ8), after 90%-Px. The tissues where rapidly immersed in RNAlater solution (Ambion, Applied Biosystems), chopped into small pieces (!5 mm) and kept overnight at 4 8C until total RNA extraction was performed.
Morphometry b-cell mass was determined by point counting morphometry on immunoperoxidase-stained sections, using a 48-point grid to obtain the number of intercepts over b-cells and over other pancreatic tissue (Montanya & Tellez 2009 ). The tissue sections were stained for insulin with a rabbit anti-human insulin antibody (antibody description given in Table 1 ) and visualised with the LSABC HRP system (DAKO, Carpinteria, CA, USA). A nomogram relating number of points counted to volume density and expected relative standard error in percentage of mean (!10%) was used to determine the number of intercepts needed for a representative sampling (Weibel 1979) . Approximately, 20 000 points were counted in each pancreas, and at least two sections (150 mm apart) were included for each animal. Ductal cell mass was determined on keratin 20 (KRT20)-labelled samples using the above described procedure. At least two sections (150 mm apart) were included for each animal. All measurements were performed by a blinded observer. The b-cell and ductal-cell relative volume was calculated by dividing the number of points over b-cells or ductal-cells by the total number of points over pancreatic tissue. Mass of b-cell and ductal cell mass was obtained by multiplying its relative volume by the pancreas weight.
The focal areas of regeneration were identified based on mesenchymal cell infiltration and observation of ductal structures with KRT20-positive cells (Li et al. 2010) . The relative volume was determined on slides stained for KRT20/vimentin (Table 1) using the Leica Application Suite (LAS) Software (Leica Microsystems, Heerbrugg, Switzerland).
Immunostaining and image analysis
The primary antibodies are listed in Table 1 . For NKX6.1 immunofluorescence, the biotin-streptavidin amplification For b-catenin, images were acquired with an Olympus DP70 camera-associated software under equal exposure time and brightness/contrast settings. For KRT20, images were acquired from a confocal microscope (TCS-SL Spectral Confocal Microscope, Leica, Wetzlar, Germany) using identical settings among samples. For co-expression analysis, 488 and 647 Alexa Fluor-labelled secondary antibodies were used in order to rule out false doublepositive cells. Fluorescence intensity was determined by using the open-source image processing package based on ImageJ, FIJI Software (National Institutes of Health, Bethesda, MD, USA).
Cell replication
The rats were received injections of thymidine analogue 5-bromo-2 0 deoxyuridine (BrdU; Sigma), 100 mg/kg, i.p.
1 h before the pancreas remnant was harvested. To assess b-cell replication, the sections were double stained with immunoperoxidase for BrdU using a Cell Proliferation Kit (GE Health Care, Amersham, Buckinghamshire, UK), and for insulin using a rabbit anti-human insulin antibody. Ductal cell replication was determined by double inmunofluorescence. For BrdU detection, the mouse antiBrdU (1:100; Cell Proliferation Kit, GE Health Care) combined with the Alexa Fluor 488-labelled anti-mouse IgG (1:400) was used. Rabbit anti-cow cytokeratin antiserum (1:3000; DAKO) was used for ductal cell identification and Alexa Fluor 555-labelled anti-rabbit IgG (1:400) was used as secondary antibody. b-cell and ductal cell replication was expressed as percentage of BrdU-positive b-or ductal cells respectively. At least 1200 cells/pancreas were counted.
b-cell apoptosis
The sections were double stained with immunoperoxidase for apoptotic nuclei (black) with the TUNEL technique (In Situ Cell Death Detection Kit, ApopTag, Intergene, Oxford, UK) and for insulin (brown) using a rabbit anti-human insulin antibody (Montanya & Tellez 2009) . A minimum of 1200 cells/pancreas were counted.
RNA isolation, quantification, and retrotranscription
Pancreatic tissue was resuspended with 1 ml TRIzol reagent (Sigma) for homogenisation (Ultraturrax, Janke & Kunkel, Stauffen, Germany). Total RNA was purified according to the manufacturer's instructions (PureLink Micro-to Midi System, Invitrogen). RNA quality was assessed with the Agilent Bioanalyzer 2100 (Agilent Technologies, Inc., Santa Clara, CA, USA) and the RNA integrity number (RIN) score ranged from 6.7 to 8.3. cDNA synthesis was carried out from 5 mg of total RNA using the Superscript III First-strand cDNA synthesis system (Invitrogen).
QPCR
PCR was run in a 7900HT Fast Real-Time PCR system (Applied Biosystems) with 384-well optical plates allowing all samples to be amplified in the same run for each gene. Reactions were performed using TaqMan Gene Expression Assays and TaqMan Gene Expression Master Mix (Applied Biosystems) following the manufacturer's protocol in a final volume of 20 ml with 250 ng of cDNA in each reaction. A full listing of assays (Applied Biosystems), gene names and assay identification numbers are given in Table 2 . Relative quantities (RQs) were calculated using ABI SDS 2.2.2 RQ for 7900HT Software (Applied Biosystems) and the 2 KDDCt analysis method with eukariotic 18S rRNA as the endogenous control. Gene expression was expressed with a RQ value resulting from the calculations performed in the SDS2.2.2. RQ values were normalised to give a mean of 100 for control rats to aid in comparison across genes with varying basal abundance. The cholecystokinin receptor B (Cckbr) mRNA was undetectable in control pancreases. Thus, for analysis of Cckbr gene expression, a PxCV sample was used as a reference sample. 
Statistical analyses
Results were expressed as meansGS.E.M. Analyses were performed using GraphPad Prism 4 Software (GraphPad Software Inc, La Jolla, CA, USA), and differences among means were evaluated using the Student's t-test or the one-way ANOVA combined with Tukey's test for post hoc analysis as appropriate. A P value of !0.05 was considered significant.
Results
Metabolic evolution
Blood glucose levels were similar between SCV, PxCV, and PxCG rats throughout the study (day 3; SCV: 101G 6 mg/dl; PxCV: 119G5 mg/dl; PxCG: 111G6 mg/dl and day 14; SCV: 111G7 mg/dl; PxCV: 124G6 mg/dl; PxCG: 109G4 mg/dl; Fig. 1 ).
Upregulation of gastrin and CCKBR in pancreatic remnants early after Px
Gastrin and its high-affinity receptor CCKBR were transcriptionally upregulated on days 1 and 3 after Px in both PxCV and PxCG groups ( Fig. 2A and B) . CCKBR immunostaining was positive in a few acinar cells in the sham and Px groups, whereas b-cells were largely negative ( Supplementary Fig. 1 , see section on supplementary data given at the end of this article). The highest positivity was found in regenerative ductal cells from the focal areas of regeneration (Fig. 2C) . The number of CCKBR-positive cells per unit pancreatic area was higher in pancreatic remnants from PxCV rats than in SCV rats (day 3; SCV: (Fig. 2D ).
Similar ductal cell expansion in gastrin-and vehicle-treated rats . On day 1 after Px, the epithelial ductal cells of the CPD showed strong BrdU incorporation; on day 3, BrdU was mainly detected within the focal areas of regeneration. These focal areas of regeneration contained KRT20-positive ductal cells (regenerative ducts) surrounded by mesenchymal cells (Fig. 3A) , and increased in size from days 1 to 3 after Px (Fig. 3B ). Pancreatic remnant weight was similar in both Px groups (day 3; PxCV: 107.2G7.64 mg; PxCG: 99.2G5.7 mg, PZ0.42) and the KRT20-positive cell relative area was similarly increased in both Px groups compared with shamoperated rats (Fig. 3C ), indicating that gastrin did not further increase the ductal cell mass and areas of regeneration after Px.
Enhanced ductal cell dedifferentiation in gastrin-treated rats
Gene expression was analysed in the entire pancreatic remnants of PxCV and PxCG rats and in the whole remnant-equivalents of SCV rats. Initially after Px, gastrin-treated pancreatic remnants showed reduced gene expression levels of ductal-and epithelial-cell markers compared with PxCV remnants (Fig. 4A ) despite the similar increment in the relative area of ductal cell found in both Px groups (Fig. 3C) . In pancreases of sham-operated rats, KRT20 was exclusively expressed in epithelial ductal cells and centroacinar/ terminal ductal cells, with similar immunofluorescence intensity among different types of ducts (CPD, interlobular and intralobular ducts, data not shown). In Px animals, KRT20 was expressed in the ductal cells of both the focal areas of regeneration and of the rest of the remnant, although the former exhibited lower KRT20 immunofluorescence intensity (Supplementary Fig. 2A and B, see section on supplementary data given at the end of this article). In gastrin-treated animals, KRT20 fluorescence intensity was even lower than in PxCV remnants ( Fig. 4B  and C) , paralleling the lower gene expression of Krt20 in this group.
b-catenin immunoreactivity was found in the plasma membranes of ductal, acinar and islet cells in pancreases of sham-operated animals, with higher immunofluorescence intensity in ductal than in acinar cells (Supplementary Fig. 2C and D) . In pancreatic remnants, ductal cells in the focal areas of regeneration showed lower immunoreactivity for b-catenin than that for native ducts ( Supplementary Fig. 2E and F), and it was further reduced in PxCG remnants ( Fig. 4D and E) .
The ductal cells in focal areas of regeneration of PxCG remnants showed higher cell replication than those of the PxCV group (PxCV, 2.02G0.47% and PxCG, 4.23G 0.90%; P!0.05; Fig. 4F ). Overall, these results indicate that the presence of ductal-cell dedifferentiation after Px was enhanced by gastrin treatment.
Increased expression of transcription factors involved in endocrine specification by gastrin treatment
After Px, differentiation of the focal areas of regeneration into an endocrine phenotype involves the expression of pancreatic and endocrine progenitor markers in regenerative ducts, recapitulating embryonic pancreas development (Li et al. 2010) .
Gene expression of Neurog3, Neurod1 and Pdx1 was similar in SCV and PxCV remnants at all time points (Fig. 5A ). Nkx6.1 gene expression was doubled in PxCV remnants compared with SCV on day 3 after Px, but differences were not statistically significant (Fig. 5A) . In contrast, in PxCG remnants gene expression of Neurog3 and NeuroD1 on day 1 and of Pdx1 and Nkx6-1 on day 3 after Px were significantly increased compared with sham and PxCV groups (Fig. 5A ).
NEUROG3 and NKX6-1 proteins were detected in the ductal cells from the focal areas of regeneration ( Fig. 5B  and C) . On day 3 after Px, the expression of NKX6.1 in KRT20-positive cells was significantly increased in gastrin-treated animals (PxCG, 57.6G3.9% and PxCV, 41.7G0.7%; PZ0.028; Fig. 5D ). On day 3 after surgery, single b-cells or small b-cell clusters were found within the areas of regeneration continuous to or in close contact with ducts ( Fig. 6A) , at a density of 3G0.33 and 8G1.21 insulin-positive cells/mm 2 in PxCV and PxCG pancreases respectively (PZ0.004). The number of small b-cell clusters (less than five insulin-positive cells) within the regenerative pancreas was significantly increased in PxCG remnants (Fig. 6B) . On day 3 after surgery, b-cell apoptosis was similar in both Px groups and 2.5 times higher compared with sham-operated rats, but differences did not reach statistical significance (Fig. 6C) . b-cell replication was increased similarly in Px groups compared with sham-operated rats (Fig. 6D) . Replication was increased in b-cells within the focal areas of regeneration compared with those in the non-regenerating pancreas in PxCV and PxCG rats (Fig. 6E) .
b-cell relative area was similar between Px groups on day 1 after Px. On day 3, it was significantly increased in PxCG, compared with PxCV rats, and remained higher on day 14 (Fig. 6F) . Accordingly, b-cell mass was increased in PxCG rats on days 3 and 14 after Px compared with PxCV and SCV rats. As previously reported, b-cell mass was increased in PxCV rats compared with SCV, on day 14 (Fig. 6G ).
Discussion
In this study, we showed that the expansion of the ductal cell compartment in the regenerative pancreas was paralleled by downregulation of KRT20 and b-catenin and by NKX6-1 expression in ductal cells. Gastrin treatment enhanced Px-induced ductal cell dedifferentiation, further stimulated ductal cell NKX6-1 expression in the regenerative pancreas, increased the number of newly formed b-cells and fostered a rapid b-cell mass expansion.
Gastrin and its high-affinity receptor, CCKBR, were upregulated after 90% Px, providing a mechanistic explanation for the effects of gastrin treatment. In addition, this expression of gastrin and CCKBR has similarities with their expression during the secondary transition in embryonic pancreas development (Larsson Gastrin treatment did not modify ductal cell mass expansion after Px, but enhanced the dedifferentiation of ductal cells in the regenerative pancreas. Ductal cell mass was similar in gastrin-and vehicle-treated Px rats as shown by the similarly increased ductal cell relative volume and focal areas of regeneration in pancreatic remnants in the two groups. In contrast, gene expression of ductal cell markers (Krt20, Car2, Prom1, Hnf1b and Hnf6) in the pancreatic remnants of gastrin-treated rats was lower compared with vehicle-treated rats. Ductal cells in the focal areas of regeneration of pancreatic remnants from vehicle-treated Px rats showed reduced expression of KRT20 and b-catenin, supporting the previously reported acquisition of a dedifferentiated phenotype in regenerative ductal cells (Li et al. 2010) . Gastrin treatment resulted in further dedifferentiation of ductal cells in the regenerative pancreas, as indicated by the even lower expression of KRT20 and b-catenin that was concordant with the lower gene expression of ductal cell markers in this group compared with vehicle-treated Px rats. Mature ductal cells are characterised by strong and polarised KRT20 expression (Bouwens et al. 1995) , while multipotent embryonic ductal cells show absent or minor unpolarised expression of the intermediate filament (Di Bella et al. 2009 ). In addition, KRT20 expression has been found to be downregulated in the in vitro human ductal-to-b-cell differentiation process (Dodge et al. 2009 , Téllez et al. 2013 , supporting differential KRT20 expression in ductal cells depending on the maturation status. On the other hand, the reduced cytoplasmic accumulation of b-catenin in newly formed regenerative ducts could facilitate delamination of endocrine precursors from ductal structures as found in embryonic pancreas development (Kesavan et al. 2009 , Gouzi et al. 2011 . It has been recently reported that loss of E-cadherin accumulation in the plasma membrane by sustained expression of Neurog3 in the mouse endoderm is sufficient to trigger cell delamination from the endodermal epithelium (Gouzi et al. 2011) . Thus, the lower gene expression of ductal cell markers and KRT20 and b-catenin immunoreactivity indicates enhanced ductal dedifferentiation in gastrin-treated rats after Px.
Pancreatic remnants of gastrin-treated rats showed transiently increased gene expression of the endocrine progenitor markers Neurog3, Neurod1, Pdx1, and Nkx6-1 initially after surgery, indicating that gastrin treatment enhanced Px-induced cell progenitor competence of ductal cells in the regenerative pancreas. Neurog3 is required for pancreatic endocrine cell differentiation during embryonic development (Apelqvist et al. 1999 , Gradwohl et al. 2000 , GrapinBotton et al. 2001 ). In the post-natal pancreas, Neurog3 expression is clearly downregulated and it is only very modestly expressed in mature islet cells (Gu et al. 2002 , Kodama et al. 2005 , Dror et al. 2007 , Joglekar et al. 2007 , Wang et al. 2009 . In rodent models of pancreatic endocrine regeneration, Neurog3 gene expression is significantly upregulated (Xu et al. 2008 , Solar et al. 2009 , Kopp et al. 2011 and it has been found in the pre-existing b-cells (Kopp et al. 2011 , Xiao et al. 2013 , within ducts (Xu et al. 2008) and/or in mesenchymal cells next to ducts . In this study, we have found Neurog3 expression in regenerative ducts after Px, in accordance with previous data (Li et al. 2010) . We have identified the presence of mesenchymal cells positive for Neurog3 surrounding the regenerative ducts. A similar finding has been recently reported in a mouse model of induced b-cell neogenesis by Pax4 missexpression in a-cells, where Neurog3-induced epithelial-to-mesenchymal transition (EMT) was identified in duct-lining cells (Al-Hasani et al. 2013). It has recently been reported that sustained expression of Neurog3 in the mouse endoderm is sufficient to trigger EMT and cell delamination from the endodermal epithelium (Gouzi et al. 2011) . Therefore, the expression of Neurog3 in duct cells and in mesenchymal cells may indicate that EMT occurred in the ductal epithelium of focal areas of regeneration. Nuclear NKX6-1 expression was found in some regenerative ductal cells in PxCV rats and it was significantly increased in pancreatic remnants of gastrintreated rats. NKX6-1 is required for the development of endocrine a and b cells in the foetal pancreas (Henseleit et al. 2005) and drives pancreatic progenitor cells into the endocrine/ductal cell lineage. Specifically, continuous expression of NKX6-1 in the entire pancreatic progenitor pool significantly represses Ptf1a expression, preventing acinar cell differentiation, and favours an endocrine over a ductal cell fate choice (Schaffer et al. 2010 ). In the post-natal pancreas, nuclear NKX6-1 expression is restricted to endocrine b-cells (Sander et al. 2000) , and it has been shown that induction of NKX6-1 expression in PDX1-expressing liver cells promotes endocrine cell reprogramming (Gefen-Halevi et al. 2010) . The presence of NEUROG3 and NKX6-1 expression in a subpopulation of ductal cells indicates that these cells have an endocrine progenitor-like phenotype. Their increased number in the gastrin-treated group provides a potential mechanism for the increased neogenesis in these animals.
The increased b-cell relative area and mass found in PxCG group compared with PxCV group pancreatic remnants initially after Px was most probably due to differences in b-cell neogenesis, because b-cell replication, apoptosis and pancreas weight were similar for the two Px groups. Differences in b-cell relative area and mass between the PxCV and PxCG groups persisted 2 weeks after Px, indicating that early expansion of the b-cell compartment determined the long-term evolution of b-cell mass.
This study supports the concept that after partial Px, in addition to b-cell replication, new b-cells are also formed by neogenesis, that neogenesis contributes to b-cell mass expansion and that the process is enhanced by gastrin treatment. The lower expression of KRT20 and b-catenin in the regenerating ducts of gastrin-treated Px rats and the increased number of duct cells expressing NKX6-1 indicate that gastrin enhanced dedifferentiation and progenitor competence of the ductal compartment of the pancreas. We propose that this would lead to an enrichment of the endocrine progenitor pool, which could represent a source of new endocrine cells.
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